UPC CoA 1/2025
Jan 3, 2025·EP2643717: COLOR-MIXING CONVERGENT OPTICAL SYSTEM
- Case details
- StatusCase ClosedActionAppealCategoryMain Appeal
- Parties
- Division
- Court of Appeal
- Technology
- Display & Signage
- Language
- German
- First decided
- May 26, 2025
- Last decision
- Nov 27, 2025
- 2025-05-26Injunction denied
The Court of Appeal denied the application by Chainzone Technology (Foshan) Co., Ltd. (intervener/defendant) for suspensive effect of its appeal against the infringement order of the Vienna Local Division (15 January 2025) in proceedings between SWARCO FUTURIT and STRABAG. Chainzone failed to demonstrate manifest errors in the first-instance decision concerning EP 2 643 717 (a colour-mixing convergent optical system). The order confirming the injunction against STRABAG therefore remained enforceable. This is the German language version; an English translation exists (see finalorderuspensiveeffect EN.pdf). Note: the referenced case number in the parties section is UPC_CoA_70/2025 (Strabag appeal) and UPC_CoA_1/2025 (Chainzone appeal).
Legal issues:Application for suspensive effect under R.223 RoPManifest error standard for suspensive effectIntermediary liabilitySecurity for enforcement under R.352.1 RoP - 2025-05-26Injunction denied
The Court of Appeal denied the application by Chainzone Technology (Foshan) Co., Ltd. for suspensive effect of its appeal against the infringement order of the Vienna Local Division concerning EP 2 643 717 (colour-mixing convergent optical system / LED optics). Chainzone failed to demonstrate that the first-instance decision was manifestly erroneous. The enforcement of the injunction against STRABAG therefore continued. Key headnotes: application for suspensive effect must itself enable the respondent to prepare and the court to decide; suspensive effect requires manifest error in the impugned order; a company director is not an 'intermediary' under Art. 63 UPCA merely by reason of their directorship; security for enforcement under R.352.1 must be ordered at the time of the decision. This is the English translation of finalordersuspensiveeffect.DE_.pdf.
Legal issues:Application for suspensive effect under R.223 RoPManifest error standardDirector liability as intermediary under Art.63 UPCASecurity for enforcement under R.352.1 RoPContent requirements for suspensive effect application
| Document title | Date | Public |
|---|---|---|
| Case Closure Formal Check | 2025-09-18 | Not public |
| Headnote-and-Keyword-Translated | 2025-06-16 | Not public |
| Outcome of the Order | 2025-03-19 | Not public |
| Anordnung Berichtigung 10x - Vizgen | 2025-03-19 | Public |
| Zustimmung Berichtigung - 10x Genomics | 2025-03-18 | Not public |
| Headnote-and-Keywords | 2025-03-13 | Not public |
| Outcome of the Order | 2025-03-11 | Not public |
| Anordnung Rückerstattung Gebühren | 2025-03-11 | Public |
| Vorläufige Verfahrensanordnung Berichtigung | 2025-03-11 | Not public |
| Receipt | 2025-03-07 | Not public |
| 2025-03-07-EP-782-Antrag-R-353-VerfO-10x-Genomics-v-Vizgen-BG-26-2025_CMS.pdf | 2025-03-07 | Not public |
| Receipt | 2025-03-06 | Not public |
| Antrag auf Kostenrückerstattung - 10x Genomics | 2025-03-06 | Not public |
| Headnote-and-Keywords | 2025-03-06 | Not public |
| Outcome of the Order | 2025-03-05 | Not public |
| Anordnung Rücknahme | 2025-03-05 | Public |
| 2025-02-12-EP-782-Zust-Berufungsrueckn-10x-Genomics-v-Vizgen-BG-26-2025_CMS | 2025-02-12 | Not public |
| Verfahrensanordnung Rücknahme | 2025-02-10 | Not public |
| Receipt | 2025-02-10 | Not public |
| Acknowledgement-of-lodging | 2025-02-10 | Not public |
| Rechtsanwaltsausweis | 2025-02-10 | Not public |
| 2025-01-29 - EP 782 - Antrag auf Aenderung der Details des Vertreters - 10x Genomics v Vizgen - BG 4706-2025.pdf | 2025-02-10 | Not public |
| Rücknahme Berufung - 10x | 2025-02-10 | Not public |
| Acknowledgement-of-lodging | 2025-02-03 | Not public |
| 2025-02-03-EP-782-BE-10x-Genomics-v-Vizgen-BG-26-2025_CMS.pdf | 2025-02-03 | Not public |
| Acknowledgement-of-lodging | 2025-01-22 | Not public |
| Panel-Appointment | 2025-01-21 | Not public |
| Receipt | 2025-01-21 | Not public |
| Acknowledgement-of-lodging | 2025-01-21 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-01-21 | Not public |
| Anlage BP-AP-CC 1 - 10x Genomics/Harvard | 2025-01-14 | Not public |
| Schriftsatz 10x Genomics - Korrektur Formal Checks | 2025-01-14 | Not public |
| Berufung - 10xGenomics und Harvard | 2025-01-14 | Not public |
| Anlage -Zahlungsbeleg | 2025-01-14 | Not public |
| Anlage BP AP CC 2 - 10x Genomics | 2025-01-14 | Not public |
| Acknowledgement-of-lodging | 2025-01-13 | Not public |
| Application | 2025-01-13 | Not public |
| Formal-checks_Request-for-correction | 2025-01-08 | Not public |
| Acknowledgement-of-lodging | 2025-01-03 | Not public |
| Anlage -Zahlungsbeleg | 2025-01-03 | Not public |
| Anlage BP-AP-CC 1 - 10x Genomics/Harvard | 2025-01-03 | Not public |
| Berufung - 10xGenomics und Harvard | 2025-01-03 | Not public |